TrialClinical and experimental nephrology2024

Tenapanor for peritoneal dialysis patients with hyperphosphatemia: a phase 3 trial.

Masaaki Nakayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.